Digestive Diseases and Microbiota
Basic/translational research
Modify by Institut d'Investigació Biomèdica de Girona (IDIBGI) - H. Universitari Dr. Josep Trueta
·Girona ·

The group Malalties Digestives i Microbiota of IDIBGI focuses on studying the etiology of digestive diseases and the role of risk factors related to lifestyle and the role of microorganisms living in the intestine. It comprises a multidisciplinary team with basic and clinical researchers. The methodology employed includes observational studies at the phenotypic and molecular level, and instrumental studies to test causality.

Main publications in pancreatic cancer:

  1. Carreras-Torres R, johansson M, Gaborieau V, et al. The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study. J Natl Cancer Inst. 2017 Sep 1;109(9):djx012. doi: 10.1093/jnci/djx012.
  2. Hatcher C, Richenberg G, Waterson S, et al. Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancer. Sci Rep. 2023 Apr 12;13(1):5968. doi: 10.1038/s41598-023-31840-0.
  3. Bossé Y, Li Z, Xia J, et al. Transcriptome-wide association study reveals candidate causal genes for lung cancer. Int J Cancer. 2020 Apr 1;146(7):1862-1878. doi: 10.1002/ijc.32771.
Robert Carreras

Principal Investigator

Group members

  • Robert Carreras
  • Xavier Aldeguer
  • Jesús García-Gil
  • Esther Fort
  • Laura Pardo
More information

Other groups

Virología e inmunología celular – Julià Blanco Arbués

Nuestro grupo en IrsiCaixa se centra en el desarrollo de estrategias terapéuticas innovadoras contra tumores sólidos, con un énfasis particular en el cáncer de páncreas. El grupo integra enfoques inmunológicos, moleculares y traslacionales para diseñar y evaluar...

Neoantigens and Vaccines Against Cancer – Núria de la Iglesia

The Neoantigens and Cancer Vaccines group (NeoVaCan) is part of the IrsiCaixa Institute for Research on Immunopathologies, a center dedicated to the study of diseasesrelated to the immune system, ranging from viral infections, such as HIV or SARS-CoV-2, to cancer. Our...

Angiogenesis Group – Alfredo Martínez Ramírez

The Angiogenesis Group is part of the Oncology Area of the Biomedical Research Center of La Rioja (CIBIR), located in Logroño, Spain. As the name implies, the Angiogenesis Group focuses on the process of angiogenesis in relation to cancer and other relevant diseases...

See all groups